Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bourgeois, H [1 ]
Lemerre, D [1 ]
Chicoyneau, V [1 ]
Paitry, T [1 ]
Chleze, S [1 ]
Fruge, F [1 ]
Boita, F [1 ]
Meurice, JC [1 ]
Daban, A [1 ]
机构：
[1] Reg Univ Hosp Miletrie, F-86021 Poitiers, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81462-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1042
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [21] Ifosfamide and gemcitabine: A phase II trial in advanced inoperable non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 15 - 18
  • [22] Phase II clinical trial of Gemcitabine and ifosfamide in inoperable non-small cell lung cancer (NSCLC)
    Cubedo, R
    Espana, P
    Provencio, M
    Jorge, M
    Sanchez, A
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [23] Promising activity of a novel non-cisplatin based regimen in advanced non-small cell lung cancer (NSCLC): A phase II study of Gemcitabine (G), ifosfamide (I) plus vinorelbine (N)
    Castellano, D
    Lianes, P
    Arcediano, A
    Garcia-Carbonero, R
    Paz-Ares, L
    Gomez-Martin, C
    Guerra, JA
    Cortes-Funes, H
    ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [24] Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC).
    Hoang, T
    Kim, K
    Merchant, J
    Traynor, AM
    Ahuja, HG
    Masters, GA
    McGovern, JD
    Oettel, KR
    Sanchez, FA
    Schiller, JH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 642S - 642S
  • [25] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Yun Fan
    Neng-ming Lin
    Sheng-lin Ma
    Lü-hong Luo
    Luo Fang
    Zhi-yu Huang
    Hai-feng Yu
    Feng-qin Wu
    Acta Pharmacologica Sinica, 2010, 31 : 746 - 752
  • [26] Phase II trial of gemcitabine plus cisplatin in patients with advanced non-small cell lung cancer
    Fan, Yun
    Lin, Neng-ming
    Ma, Sheng-lin
    Luo, Lue-hong
    Fang, Luo
    Huang, Zhi-yu
    Yu, Hai-feng
    Wu, Feng-qin
    ACTA PHARMACOLOGICA SINICA, 2010, 31 (06) : 746 - 752
  • [27] Gemcitabine and cisplatin in advanced non small cell lung cancer (NSCLC)
    Garcia-Gomez, R
    Lopez-Criado, P
    Guevara, S
    Lahoz, C
    Chaib, C
    Gonzalez, C
    Santiago, J
    De Alvaro, J
    Carrion, R
    Perez-Manga, G
    ANNALS OF ONCOLOGY, 1998, 9 : 93 - 94
  • [28] Phase I/II trial of gemcitabine plus cisplatin and etoposide in patients with small-cell lung cancer
    De Marinis, F
    Migliorino, MR
    Paoluzzi, L
    Portalone, L
    Ariganello, O
    Cortesi, E
    Gamucci, T
    Gasperoni, S
    Cipri, A
    Martelli, O
    Nelli, F
    LUNG CANCER, 2003, 39 (03) : 331 - 338
  • [29] PHASE-II TRIAL OF IFOSFAMIDE (I), CISPLATIN (C) AND 4-EPIRUBICIN (E) IN ADVANCED NONSMALL CELL LUNG-CANCER (NSCLC) - A PRELIMINARY-REPORT
    MALZYNER, A
    TERRAFILHO, M
    CAPONERO, R
    CUKIER, A
    DONATO, EW
    MAZZINI, V
    TEIXEIRA, LR
    FERIANCIC, CV
    VARGAS, FS
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A749 - A749
  • [30] A phase I/II study of pembrolizumab (P) with gemcitabine (G) in patients (Pts) with previously-treated advanced non-small cell lung cancer (NSCLC): Phase I safety results
    Sanborn, Rachel E.
    Duffy, Regan M.
    Fisher, Brenda K.
    Perlewitz, Kelly Shea
    Redmond, William L.
    Koguchi, Yoshinobu
    Fox, Bernard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345